Loading patent…
AssigneePolytechnic Institute of New York University
InventorsRichard A. Gross, Vishal Shah, Gustavo Doncel
Estimating the term…
A method for neutralizing or inactivating a virus, and neutralizing or inactivating HIV using sophorolipids having antiviral properties produced by synthesizing the sophorolipid by fermentation of Candida bombicola in a fermentation media to form a natural mixture of lactonic sophorolipids compounds and non-lactonic sophorolipids compounds and utilizing the natural mixture as an antiviral agent, and/or separating the lactonic sophorolipids from the natural mixture to form a lactonic fraction and mixing all remaining fractions to form a non-lactonic fraction and utilizing the lactonic fraction and/or the non-lactonic fraction as an antiviral agent, and sophorolipid compounds for use as antiviral agents.
A method for neutralizing or inactivating a virus by treating the virus with an effective amount of a 17-L-[(2′-O-β-D-glucopyranosyl-p-D-glucopyranosyl)-oxy]-cis-9-octadecenoate sophorolipid compound.
A method for neutralizing or inactivating HIV by treating the HIV with an effective amount of a 17-L-[(2′-O-β-D-glucopyranosyl-p-D-glucopyranosyl)-oxy]-cis-9-octadecenoate sophorolipid compound.
Dependencies are inferred from the claim text.